|
If you can't view this page, please visit: http://www.gtcbio.com/newsletter/NITSii13-w.htm XGWA-5902
|
|
Early Registration Discount Ending on December 30th!
Register for the 2nd Novel Immunotherapeutics Summit
January 30 - February 1, 2013 in San Diego, CA
|
|
Dear Colleague,
Registration for the 2nd Novel Immunotherapeutics Summit grants access to all four concurrent tracks:
. 5th Immunotherapeutics and Immunomonitoring
. 11th Cytokines and Inflammation
. 2nd Allergy Drug Discovery and Development
. Immunogenicity and Immunotoxicity
Taking place on Jan 30 - Feb 1, 2013 in San Diego, CA, the 2nd Novel Immunotherapeutics Summit brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics range from cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity, immunotoxicity, allergy and asthma will be discussed at the summit.
Attend the pre-conference Workshop: Immune Responses in Tumor Microenvironment. This pre-conference workshop is included in the 2nd Novel Immunotherapeutics Summit and kicks off the Summit with presentations from pharma and academia with a round table discussion with experts in the field.
Register today and save 10% off the regular price!
Register 3 people for the price of 2! Use discount code rcdvb.
|
| KEYNOTE SPEAKERS |
Anne De Groot, CEO/CSO, EpiVax
Erwin Gelfand, Chairman, Department of Pediatrics, National Jewish Health
Ron Levy, Professor of Medicine and Chief, Division of Oncology, Stanford University
Joost J. Oppenheim, Chief, Laboratory of Molecular Immunoregulation, NIH, NCI
|
| FEATURED SPEAKERS |
Ian Ahnfelt-Ronne, Corporate Vice President, Novo Nordisk A/S
William Barchuk, Senior Director, Immunology Translational Medicine Development, Janssen Research and Development
Jacques Descotes, Professor and Head, Poison Center and Pharmacovigilance, Lyon University General Hospitals
Juan Carlos Lopez-Talavera, Vice President, Global Development Lead, Global Development & Medical Affairs, Research and Development, Bristol-Myers Squibb Company
Dean Metcalfe, Chief, Laboratory of Allergic Diseases, NIAID, NIH
Tomas Mustelin, Vice President, Research, Respiratory, Inflammatory, and Autoimmune Diseases, MedImmune
Thomas Platts-Mills, Head, Division of Allergy, Asthma & Immunology, University of Virginia
Jack Ragheb, Principal Investigator Laboratory of Immunology, Therapeutic Proteins Office of Biological Products, CDER, FDA
Helen Sabzevari, Global Head of Immuno-Oncology, EMD Serono
Puja Sapra, Director, Oncology Research Unit, Pfizer
Ronald Swanson, Senior Director, Biologics Research, Janssen R&D
Steven Swanson, Executive Director, Amgen
Nicholas Valiante, Head of Immunology, U.S. & Global Head of Immuno-Therapy, Novartis
Yihong Yao, Director, Head Of Pharmacogenomics and Bioinformatics, Translational Sciences, MedImmune
...and more!
For an updated speaker list, click here.
Register today and save 10% before Dec 30th!
Sign up 3 people for the price of 2! Use discount code rcdvb.
|
| CALL FOR PAPERS! |
To be considered for an oral presentation, please submit an abstract by December 30, 2012. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
|
|
Business Development & Exhibiting Opportunities contact Maribel Cortes, ![]() 626-256-6405 x102 or spex@gtcbio.com
|
| <hr/> |
|
GTC's Upcoming Conferences
2nd Novel Cancer Therapeutics Summit
February 25-26, 2013 Las Vegas, NV
20% discount before December 25th!
3rd Ubiquitin Research and Drug Discovery
February 25-26, 2013 Las Vegas, NV
20% discount before December 25th!
4th Cancer Targets and Therapeutics
February 25-26, 2013 Las Vegas, NV
20% discount before December 25th!
2nd Oncology Partnering & Deal-Making
February 25-26, 2013 Las Vegas, NV
20% discount before December 25th!
Biomarker Summit 2013
March 20-22, 2013 San Francisco, CA
20% discount before January 20th!
6th Oncology Biomarkers
March 20-22, 2013 San Francisco, CA
20% discount before January 20th!
2nd Inflammatory & Immunological Biomarkers
March 20-22, 2013 San Francisco, CA
20% discount before January 20th!
2nd Neurological Biomarkers
March 20-22, 2013 San Francisco, CA
20% discount before January 20th!
5th Ocular Diseases & Drug Development
March 20-22, 2013 San Francisco, CA
20% discount before January 20th!
3rd Cancer Immunotherapy and Immunomonitoring (CITIM 2013)
April 22-25, 2013 Krakow, Poland
20% discount before February 22nd!
Diabetes Summit 2013
April 29-30, 2013 Boston, MA
20% discount before February 28th!
6th Diabetes Drug Discovery & Development
April 29-30, 2013 Boston, MA
20% discount before February 28th!
3rd Diabetes Partnering & Deal-Making
April 29-30, 2013 Boston, MA
20% discount before February 28th!
Stem Cell Summit 2013
April 29-30, 2013 Boston, MA
20% discount before February 28th!
Stem Cell Research & Regenerative Medicine
April 29-30, 2013 Boston, MA
20% discount before February 28th!
Stem Cell Commercialization & Partnering
April 29-30, 2013 Boston, MA
20% discount before February 28th!
Drug Discovery Summit 2013
May 8-10, 2013 Boston, MA
20% discount before March 8th!
6th Imaging in Drug Discovery
May 8-10, 2013 Boston, MA
20% discount before March 28th!
7th Drug Design & Medicinal Chemistry
May 8-10, 2013 Boston, MA
20% discount before March 28th!
8th Protein Kinases in Drug Discovery
May 8-10, 2013 Boston, MA
20% discount before March 28th!
Orphan Drugs Research & Commercialization
May 8-10, 2013 Boston, MA
20% discount before March 28th!
|
Комментарии